Stem Cells International

Stem Cells International / 2021 / Article

Corrigendum | Open Access

Volume 2021 |Article ID 9789181 | https://doi.org/10.1155/2021/9789181

Bishao Sun, Xing Luo, Chengfei Yang, Peilin Liu, Yang Yang, Xingyou Dong, Zhenxing Yang, JieXu, Yuanyuan Zhang, Longkun Li, "Corrigendum to “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro”", Stem Cells International, vol. 2021, Article ID 9789181, 3 pages, 2021. https://doi.org/10.1155/2021/9789181

Corrigendum to “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro”

Received13 Apr 2021
Accepted13 Apr 2021
Published24 Apr 2021

In the article titled “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro” [1], the authors identified that the incorrect figure was mistakenly uploaded in Figure 1(d). The authors have provided the corrected Figure 1 as below and confirm that this does not affect the results and conclusion of the article.

References

  1. B. Sun, X. Luo, C. Yang et al., “Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro,” Stem Cells International, vol. 2019, Article ID 8035076, 13 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2021 Bishao Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views96
Downloads396
Citations

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.